A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine
Clinical trial NCT05636319 · UNKNOWN
Trial details
- NCT number
- NCT05636319
- Sponsor
- Suzhou Abogen Biosciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2023-04-30
- Enrollment
- 14168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.